Member Info for Soupdragon78

Halespur, actually would be good judgement if true, Skype is much better security, Zoom just has weirdos hacking in to watch.

At least Bunsen has taken over Trader..’s post from a month ago saying Dan was in a meeting and about to issue the rns.

The joy of forums.

I’m expecting news to come with a 50p off voucher for Spearmint Rhino, so if he betters that then woohoo!

Not likely, nfx finals are usually in July

Just to go back to my original point, Brooko says Dan knowingly lied in his December podcast about payment in Jan.
The below timeline shows he could not possibly have known what was to happen as it was all after his podcast.
Yes, he has been naive in providing a running commentary to appease shareholder demand for info. But I don’t think the company have been deliberately misleading.

In brief the timeline is,

7 jan - Yatai announced an egm with agenda item to dismiss Jun Ren
23 Jan - egm voted to dismiss Jun Ren
24 Jan - DT sold
4 feb - DT told company of his sell

Understand your reasoning chablard, but how many companies rns about a director of another company being dismissed?

Also Hale if you use google chrome you can right-click and it’ll give you the option to translate the page you are in.
Here is Yatai szse page

http://www.szse.cn/application/search/index.html?keyword=%E4%BA%9A%E5%A4%AA%E8%8D%AF%E4%B8%9A&r=1589007098729

And intriguingly, Jun Ren’s wife still owns 6% of Yatai shares

Hale, for the Chinese text, I just copy paste it from the link (click and drag over the text to turn it blue, press ctrl A to select all) then go to Bing Translator online and it’ll do the job.
Still not easy to tell what’s going on as the Chinese are as bad as the rest of the financial world for how they write financial statements.

On NSB it’s difficult to tell. The sequence of events I know are:
Yatai Had concerns about income guarantees from NSB.
Yatai sent a group to audit but they could get access to info.
Yatai declared that NSB was ‘out of their control’ - what this actually means I don’t know.
Yatai held an egm on 23 jan to vote to dismiss Jun Ren and a supervisor of Yatai. Not clear whether this covered his role at NSB which he founded.
Yatai announce a £120m loss for the year and write off NSB
Yatai biggest shareholder (36%) has his shares frozen on 7 April
Chinese authorities still investigating.

ps. Halespur, DT didn't sell on inside knowledge, it was made public by Yatai at the time that Jun Ren had been dismissed, just nobody here looked on the Schenzen Exchange website to see it.

Too much emotional investing going on here. No one cares how much someone else makes, I'll applaud someone who makes £1 as much as someone who makes £1m.

Anyway back to the story, Dan was naive in his declarations of times when he couldn't have known if they'd be achieved.

No he didn't lie in December because as Yatai's own filings show, they didn't even know what was going on until mid Jan.

Anyway, to add something else to the mix, it looks like theres a further power struggle at the top of Yatai with the controlling shareholder being frozen yesterday.

http://www.szse.cn/disclosure/listed/bulletinDetail/index.html?a4c84920-52ee-4bf5-a71c-ad66e1bc6a9d

Thanks Mars, personally I don’t see it that far on yet.
My take would be that the ‘discovery’ of NXP004 talked about last November was the hypothetical academic work done, this would then be followed with lab test work done internally by the company to formulate the patent for application. I would expect the next we hear to be the submission of the patent application.
Purely my supposition.

Mars, where is your evidence that Newcastle Uni would have results on NXP004 by June?

“With 4 we will be due clinical results from Newcastle Uni ...”

ATtrades, sorry but you’ve got NXP001 completely wrong. It’s a CINV treatment which is a major problem for cancer sufferers.

Ps. Interesting how Aim4 was silent after earlier trying his usual pump and dump tactics on Twitter, saying it was ‘bargain basement’ price, then doesn’t comment when a company RNS comes out and the price drops.

Oh dear Brooko doesn’t seem to know FCA DTR 5.1 rules on notification of holdings.
Furthermore, why would someone who sold in January come back today to a stock they don’t hold just to try and make this case?

Also the CFO resigned last year and hasn’t been replaced. Plus Alan Chorlton sold 6m shares in November just after the Times rumour and didn’t declare till this February which is even worse than DT is supposed to have done.

Simple answers, not directly a covid stock and nobody here knows why the resignations happened.

Not sure why there would be a covid element. The target is treatment of fibrosis and if a result of covid is fibrosis then this will be reflected in increased treatment and sales.
If anything a larger quantity of predicted sales will reduce the percentage royalty.